This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: MSFT, RHT, PCLN

Stocks in this article: RHT CVC DFS PCLN MSFT

Updated throughout


ADTRAN (ADTN) downgraded at Think to Hold from Buy, ThinkEquity said. $35 price target. Fairly valued at current levels.

American Tower (AMT) rated new Outperform at Credit Suisse. $75 price target. Market is not pricing in long-term growth potential.

TD Ameritrade (AMTD) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Valuation call, based on a $20 price target.

Armstrong World (AWI) downgraded at Keybanc from Buy to Hold, Keybanc said. Valuation call, as the stock is already pricing in double-digit EBITDA growth over the next couple of years.

Blackrock (BLK) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Valuation call, based on a $210 price target.

Buffalo Wild Wings (BWLD) downgraded at Wedbush from Outperform to Neutral, Wedbush said. $90 price target. Wing costs remain high.

Crown Castle (CCI) rated new Neutral at Credit Suisse. Valuation call, based on a $54 price target.

Coach (COH) rated new Buy at Argus Research. $90 price target. Company can continue to expand in China.

Dana Holding (DAN) rated new Buy at BofA Merrill. $21 price target. Diversification to help drive success.

Digital Realty Trust (DLR) downgraded at Jefferies to Hold from Buy, Jefferies said. $73 price target. Lowered on valuation.

Endo Pharmaceuticals (ENDP) rated new Buy at Cantor Fitzgerald. $50 price target. Business is resilient and the company generates solid cash flow.

Morgan Stanley (MS) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $22 price target. Macro outlook remains mixed.

Microsoft (MSFT) upgraded at Argus from Hold to Buy, Argus Research said. $39 price target. Windows 8 should help the company compete in the tablet market.

Par Pharmaceutical (PRX) rated new Neutral at JP Morgan. $40 price target. Broadening pipeline and capabilities with recent acquisitions.

Royal Bank of Scotland (RBS) upgraded at UBS to Buy from Neutral, UBS said. $10.19 price target. Better GDP outlook supports a classic recovery play.

Red Hat (RHT) downgraded at Morgan Stanley from Overweight to Equal-weight, Morgan Stanley said. Valuation call, as the stock has outperformed by 24% year-to-date.

1 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs